microRNA drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (25)
Papers in which this entity is mentioned.
- Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium. (2026)
- Genome modelling and design across all domains of life with Evo 2. (2026)
- Tree-based differential testing using inferential uncertainty for RNA-seq. (2025)
- Machine learning approaches to the identification of children affected by prenatal alcohol exposure: A narrative review. (2024)
- Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium. (2024)
- Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects. (2023)
- Fetal Alcohol Spectrum Disorders: Awareness to Insight in Just 50 Years. (2022)
- Application of third-generation sequencing in cancer research. (2021)
- Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
- The Immune Landscape of Cancer. (2018)
- Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. (2018)
- Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm. (2017)
- Gene-environment interactions in development and disease. (2017)
- Tools and best practices for data processing in allelic expression analysis. (2015)
- Design and bioinformatics analysis of genome-wide CLIP experiments. (2015)
- RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. (2014)
- MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. (2014)
- P-value-based regulatory motif discovery using positional weight matrices. (2013)
- Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. (2012)
- Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. (2011)
- ViennaRNA Package 2.0. (2011)
- Mechanisms and consequences of alternative polyadenylation. (2011)
- Transcriptional and epigenetic mechanisms of addiction. (2011)
- Focus on: the use of animal models for the study of fetal alcohol spectrum disorders. (2011)
- 3' end mRNA processing: molecular mechanisms and implications for health and disease. (2008)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| microrna | drug | 50 | 99 |
| micrornas | drug | 31 | 38 |
| microrna | gene | 8 | 12 |
| micro rnas | drug | 2 | 4 |
| de microrna | drug | — | — |
| small regulatory molecules | drug | — | — |